ÍøºìºÚÁÏ

Skip to main content

Clinical trials

  • KB407-02

    This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

    Investigator
    Jorge E Lascano
    Ages
    18 Years - N/A
    Sexes
    All
  • STOP360-IP-22

    The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of…

    Investigator
    Silvia Delgado
    Ages
    6 Years - N/A
    Sexes
    All
  • REACH-OB-23

    The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not…

    Investigator
    Jorge E Lascano
    Ages
    12 Years - N/A
    Sexes
    All